Literature DB >> 6268498

[Problems in the treatment and after care of chronic dermatoses. A clinical study on hametum ointment].

R Pfister.   

Abstract

Two groups of patients with endogenous eczema (n = 36) and toxic degenerative eczema (n = 80) were treated with Hametum Salbe and a control preparation. The present results indicate that Hametum Salbe is superior in effectiveness in treatment of atopic dermatitis compared to the control preparation. There was no difference in therapeutical effectiveness in the treatment of primary irritant contact dermatitis. For treatment and interval therapy as well as for long-term treatment of chronic dermatoses Hametum Salbe is a valuable dermatological preparation which can be used without any risk in long-term therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268498

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  5 in total

1.  A placebo controlled clinical trial investigating the efficacy of a homeopathic after-bite gel in reducing mosquito bite induced erythema.

Authors:  N Hill; C Stam; S Tuinder; R A van Haselen
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  The efficacy of Prrrikweg gel in the treatment of insect bites: a double-blind, placebo-controlled clinical trial.

Authors:  N Hill; C Stam; R A van Haselen
Journal:  Pharm World Sci       Date:  1996-01

3.  Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema.

Authors:  H C Korting; M Schäfer-Korting; W Klövekorn; G Klövekorn; C Martin; P Laux
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

4.  Anti-inflammatory activity of hamamelis distillate applied topically to the skin. Influence of vehicle and dose.

Authors:  H C Korting; M Schäfer-Korting; H Hart; P Laux; M Schmid
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Hamamelis in children with skin disorders and skin injuries: results of an observational study.

Authors:  Helmut H Wolff; Meinhard Kieser
Journal:  Eur J Pediatr       Date:  2006-12-20       Impact factor: 3.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.